Journals / Journal of Clinical and Experimental Investigations / 2011 / Cilt: 2 Sayı: 4

Acquired Factor VII deficiency associated with pneumonia

Pages
460–462
Publication Date
2011-12-01
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

No: 8/14 Etlik-Keçiören Ankara, Turkey Email: [email protected] Geliş Tarihi / Received: 17.03.2011, Kabul Tarihi / Accepted: 04.04.2011 Copyright © Klinik ve Deneysel Araştırmalar Dergisi 2011, Her hakkı saklıdır / All rights reserved

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Yazışma Adresi /Correspondence: Dr.
📊
Key Findings & Data:Murat Albayrak Yeni Etlik Cad.
💡
Conclusion & Impact:No: 8/14 Etlik-Keçiören Ankara, Turkey Email: [email protected] Geliş Tarihi / Received: 17.03.2011, Kabul Tarihi / Accepted: 04.04.2011 Copyright © Klinik ve Deneysel Araştırmalar Dergisi 2011, Her hakkı saklıdır / All rights reserved
🔬Design:Makale
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Özet

Yazışma Adresi /Correspondence: Dr. Murat Albayrak Yeni Etlik Cad. Meltem sok. Turkuaz Apt. No: 8/14 Etlik-Keçiören Ankara, Turkey Email: [email protected] Geliş Tarihi / Received: 17.03.2011, Kabul Tarihi / Accepted: 04.04.2011 Copyright © Klinik ve Deneysel Araştırmalar Dergisi 2011, Her hakkı saklıdır / All rights reserved

🔖

Cite This Article

Yokuş, O., Balçık, Ö. Ş., Albayrak, M. (2011). Acquired Factor VII deficiency associated with pneumonia. Journal of Clinical and Experimental Investigations, Cilt: 2 Sayı: 4, 460–462. https://doi.org/10.5799/ahinjs.01.2011.04.0097

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Iannello S, Prestipino M, Belfiore F. Genetic defi- ciency of factor VII and hemorrhagic diathesis. A case report and literature review. Panminerva Med 1998;40(3):226-38.
  2. Peyvandi F, Cattaneo M, Inbal A, De Moerloose P, Spreafico M. Rare bleeding disorders. Haemophilia 2008;14 Suppl 3:202-10.
  3. Croom KF, McCormack PL. Recombinant factor Vila (eptacog alfa): a review of its use in congenital he- mophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders. BioDrugs 2008;22(2):121-36.
  4. Lim S, Zuha R, Burt T, Chacko J, Scott R, Mainwaring CJ. Life-threatening bleeding in a patient with a lupus inhibitor and probable acquired factor VII deficiency. Blood Coagul Fibrinolysis 2006; 17(8):667-71.
  5. Siddiqui MA, Scott LJ. Recombinant factor Vila (Epta- cog Alfa): a review of its use in congenital or acquired haemophilia and other congenital bleeding disorders. Drugs 2005;65(8):1161-77.
  6. Peyvandi F, Mannucci P.M, Asti D, Abdoullahi M, Di Rocco N, Sharifian R. Clinical manifestations in 28 Italian and Iranian patients with severe factor VII defi- ciency. Haemophilia 1997;3: 242-6.
  7. White B, Martin M, Kelleher S, Browne P, McCann SR, Smith OP. Successful use of recombinant FVIIa (No- voseven) in the management of pulmonary haemor- rhage secondary to Aspergillus infection in a patient with leukaemia and acquired FVII deficiency. Br J Haematol 1999;106(1):254-5.
  8. Biron C, Bengler C, Gris JC, Schved JF. Acquired iso- lated factor VII deficiency during sepsis. Haemostasis 1997;27(2):51-6.
  9. Mullighan CG, Rischbieth A, Duncan EM, Lloyd JV. Ac- quired isolated factor VII deficiency associated with severe bleeding and successful treatment with recom- binant FVIIa (NovoSeven). Blood Coagul Fibrinolysis 2004;15(4):347-51.
  10. Franchini M. Recombinant factor VIIa: a review on its clinical use. Int J Hematol 2006;83(2):126-38.